Researchers@EVMS
Toggle navigation
Browse
Home
People
Departments
Research Areas
Capability Map
Publications
Events
Clinical Trials
Student Opportunities
FAQ
AUSTRALASIAN JOURNAL OF DERMATOLOGY
Journal
Overview
Identity
View All
Overview
publication venue for
Grouped follicular secondary syphilis: Case report and review of literature
2023
A case of genital and extragenital primary syphilis
2021
Improvement in patient- and physician-reported outcomes with apremilast treatment in patients with mild to moderate plaque psoriasis in the phase 3 ADVANCE trial: Analyses by baseline BSA and PASI
2022
Safety and efficacy of bimekizumab through 2 years in patients with moderate to severe plaque psoriasis: Long-term results from BE SURE randomised controlled trial and BE BRIGHT open-label extension
2022
Continued treatment with secukinumab is associated with high retention or regain of response
2019
Drug survival is superior among patients treated with guselkumab compared to adalimumab in the voyage 1 trial
2019
Dupilumab for adolescents with moderate-to-severe atopic dermatitis: Results from a phase 3, randomized, double-blinded trial
2019
Incidence of serious gastrointestinal events among tildrakizumab-treated patients with moderate to severe plaque psoriasis: Data from 3 randomized clinical trials
2019
Identity
International Standard Serial Number (ISSN)
0004-8380
Electronic International Standard Serial Number (EISSN)
1440-0960